Digital Revolution Will Not Be Free: Facilitating OTC Switches, Engaging Consumers
This article was originally published in The Tan Sheet
Digital technologies could transform how consumers shop for OTC drugs in stores, but costs could be significant, say industry consultants. Marketers are looking to create digital “touch points” such as interactive kiosks to create two-way communication between brands and customers.
You may also be interested in...
FDA official Rikin Mehta assures stakeholders that the proposed new paradigm for Rx-to-OTC switches would not create a third class of drugs, give pharmacists prescribing power or eliminate the need for consumers to visit doctors.
Sanofi-Aventis will launch nonprescription Allegra allergy relief products March 4, but the line might not beat private-label fexofenadine products to store shelves.
Under CEO Erik Fyrwald, IFF is committed to improving commercial execution across its four businesses after five years of overall underperformance.